Contact this trialFirst, we need to learn more about you.
Neuroprotective Agent
NoNO-42 for Stroke
Recruiting0 awardsPhase 2
Calgary, Alberta
This trial is part of a larger platform called ACT-GLOBAL. It is a Phase 2b study that will involve up to 600 male and female participants between the ages of 45 and
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service